Phase III ALLEGORY study met primary and all key secondary endpoints with Gazyva/Gazyvaro, an anti-CD20 monoclonal antibody designed for enhanced B cell depletionGazyva/Gazyvaro has the potential to b ...
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today statistically significant and clinically meaningful results from the Phase III ALLEGORY study of Gazyva® ...
Phase III ALLEGORY study met primary and all key secondary endpoints with Gazyva/Gazyvaro, an anti-CD20 monoclonal antibody designed for enhanced B cell depletionGazyva/Gazyvaro has the potential to ...
Everyday Health on MSN
Signs of Chronic Inflammation: Common and Surprising Symptoms
Chronic inflammation may be subtle but can indicate serious health issues. Discover common and surprising symptoms, and learn ...
Falls are common among adults with SLE and are linked to several factors, including higher disease activity, organ damage, and polypharmacy.
Chimeric antigen receptor T-cell therapy has exhibited “compelling” efficacy and safety in lupus, allowing 84% of patients to ...
Autoimmune diseases are on the rise in the U.S., with as many as 50 million Americans affected. Learn what causes them—and which symptoms could help pinpoint your problem.
A popular online athleisure wear company supporting lupus research is opening their first brick-and-mortar location in ...
Lupus is notorious for its unpredictable symptoms, which can vary significantly from person to person. Some of the most common symptoms include: Fatigue: A feeling of overwhelming tiredness that does ...
The recent passing of singer Selena has shocked fans and friends alike, highlighting the serious impact of lupus, a chronic autoimmune disease. This article explores the implications of lupus, the ...
The Lupus Foundation of America (LFA) proudly presented eight abstracts and sessions during the 2025 American College of Rheumatology (ACR) Convergence with the goal of advancing science, improving ...
Biogen Inc. (($BIIB)) announced an update on their ongoing clinical study. Study Overview: Biogen Inc. is conducting a Phase 3 clinical study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback